aod9604 fat loss efficacy clinical trials side effects Understanding AOD 9604: The Science of the “Fat-Burning” Peptide Fragment With the rising trend of

Ng Published: Endocrinology, Volume 142, Issue 12, December 2001, Pages 51825189 DOI: 10.1210/endo.142.12.8522 URL: Mouse and human cell lines were used to assess 3-adrenergic receptor (3-AR) mRNA expression, protein levels, and function following treatment with AOD9604 and human growth hormone (hGH)

Expecting visible changes in the first 1-2 weeks sets unrealistic expectations

AOD-9604 offers a distinct, IGF-1-independent lipolysis mechanism worth studying in its own right

Our medical team will design a tailored protocol to support fat metabolism, body composition, and long-term metabolic health through safe, science-backed care.

They aren't substitutes for one another they're tools matched to different mechanistic questions in metabolic research